---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-030613"
form_type: "8-K"
ticker: "CRVO"
cik: "0001053691"
company_name: "CervoMed Inc."
filed_at: "2024-10-03T23:59:59+00:00"
generated_at: "2026-05-30T21:05:40.073594+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# CervoMed terminates $20M ATM equity facility with BTIG; no shares sold

## Summary
- Terminated At-The-Market Sales Agreement with BTIG, effective October 11, 2024.
- No shares were ever issued under the $20M facility; no termination penalties apply.
- Company notified BTIG on October 1, 2024 of the termination.
- Originally entered into July 22, 2022; no proceeds or dilution occurred.

## SEC filing metadata
- accession: 0001437749-24-030613
- form_type: 8-K
- ticker: CRVO
- cik: 0001053691
- company_name: CervoMed Inc.
- filed_at: 2024-10-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053691/000143774924030613/0001437749-24-030613-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053691/000143774924030613/crvo20241002_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-030613
- JSON: https://secwatch.observer/filing/0001437749-24-030613.json
- Plain text: https://secwatch.observer/filing/0001437749-24-030613.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.